mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |